DIA Europe 2019 has ended
avatar for Friedrich Maritsch

Friedrich Maritsch

Shire Now Part of Takeda
Data Anonymization Lead
Friedrich Maritsch, Sr. Director, Data Anonymization Lead at Shire’s (now part of Takeda’s) Clinical Trial Transparency Group, holds a PhD from the University of Vienna in Austria and has over 25 years of experience in the pharmaceutical industry, working in various capacities. Friedrich was head of Clinical Data Management at Baxter and its spin-off, Baxalta, for nearly 10 years. Currently, he oversees the data de-identification, anonymization, redaction and transfer under data privacy and protection requirements. Developments on data publishing policies have accelerated the implementation of a risk-based data de-identification process for individual patient data: a key area of which Friedrich has been a chief driver for the past 4 years.